
Seasonal influenza cases continued to edge upward in most parts of the United States last week, with notable upticks in the south central, southeast, Mountain, and West Coast regions, according to the latest report today from the Centers for Disease Control and Prevention (CDC).
FluView data for the week ending November 18 show an overall 4.9% hike in flu positivity, up 0.5 percentage points from last week. The highest positivity rates were in the Mountain (11.2%), south central (7.6%), southeast (7.6%), and West Coast (7.2%) regions.
Respiratory viruses made up 3.7% of outpatient healthcare visits, which are at or above baseline in 7 of 10 Health and Human Services regions for the third week in a row. Nine jurisdictions reported moderate respiratory illness activity, and 12 characterized their activity as high or very high. The percentage of visits for respiratory illness is trending upward in only the 65-and-older age-group.
The New England and Mountain regions at are baseline, while the Mid-Atlantic, southeast, south central, and West Coast regions, as well as the region encompassing New York, New Jersey, Puerto Rico, and the US Virgin Islands, are above baseline.
Nearly 80% of cases influenza A
Weekly flu hospitalizations continue their upward creep, with 3,296 admissions this week (cumulative hospitalization rate, 2.6 per 100,000). A total of 0.07% of all deaths were due to flu, including two children. Of the 529 virus strains reported by public health labs, 79.4% were influenza A, and 20.6% were influenza B. Of the 237 influenza A subtypes, 79.3% were H1N1, and 20.7% were H3N2.
The CDC recommends that everyone aged 6 months and older be vaccinated against flu each year and emphasizes that antiviral drugs should be initiated as soon as possible after infection—particularly for high-risk patients.
So far this season, an estimated 12,000 people have been hospitalized, and 740 have died. Flu has been confirmed as the cause of death in 3 children. The CDC recommends that everyone aged 6 months and older be vaccinated against flu each year and emphasizes that antiviral drugs should be initiated as soon as possible after infection—particularly for high-risk patients.